Structures by: Quah C. K.
Total: 256
C41H39N7O5
C41H39N7O5
The Analyst (2015) 140, 4 1229-1236
a=10.244(1)Å b=13.8307(14)Å c=14.5665(14)Å
α=72.3415(18)° β=70.1280(18)° γ=75.9246(18)°
C27H22N2O5
C27H22N2O5
Organic & biomolecular chemistry (2013) 11, 30 5023-5033
a=7.4467(4)Å b=12.1591(6)Å c=12.8432(6)Å
α=84.203(1)° β=76.464(1)° γ=84.446(1)°
C17H10N2O6
C17H10N2O6
New J. Chem. (2015) 39, 7 5669
a=8.2271(12)Å b=13.429(2)Å c=13.894(2)Å
α=90° β=101.830(3)° γ=90°
C16H10N2O5
C16H10N2O5
New J. Chem. (2015) 39, 7 5669
a=21.9055(19)Å b=4.6272(4)Å c=13.7499(12)Å
α=90° β=92.655(2)° γ=90°
C22H18N4O3S,C2H6OS
C22H18N4O3S,C2H6OS
New J. Chem. (2015) 39, 11 8582
a=23.177(5)Å b=8.5606(17)Å c=23.924(5)Å
α=90° β=90° γ=90°
C25H23NO
C25H23NO
New J. Chem. (2016) 40, 8 6907
a=9.5496(7)Å b=11.3126(8)Å c=18.0480(13)Å
α=80.204(5)° β=86.141(5)° γ=89.079(5)°
C23H21NO
C23H21NO
New J. Chem. (2016) 40, 8 6907
a=9.7031(13)Å b=11.7775(14)Å c=31.570(4)Å
α=90° β=95.921(2)° γ=90°
C46H42N6O4S
C46H42N6O4S
New J. Chem. (2016) 40, 7 6414
a=9.0642(11)Å b=11.8519(14)Å c=18.732(2)Å
α=86.072(2)° β=83.458(2)° γ=81.905(2)°
C9H8N4
C9H8N4
New J. Chem. (2014) 38, 12 6230
a=7.3136(13)Å b=4.5404(8)Å c=12.823(2)Å
α=90.00° β=103.900(4)° γ=90.00°
C39H39N5O4
C39H39N5O4
RSC Adv. (2014) 4, 47 24881
a=12.0129(13)Å b=13.4609(14)Å c=22.928(2)Å
α=94.684(3)° β=91.243(3)° γ=102.218(2)°
C30H20N6NiO2,CHCl3
C30H20N6NiO2,CHCl3
RSC Adv. (2014) 4, 40 20922
a=9.6004(9)Å b=10.577(1)Å c=14.3427(14)Å
α=82.418(2)° β=81.231(2)° γ=80.012(2)°
C31H24N2O4S
C31H24N2O4S
RSC Adv. (2016)
a=7.742(4)Å b=11.180(5)Å c=15.075(7)Å
α=73.813(11)° β=85.765(12)° γ=80.157(10)°
C14H7N3O2S
C14H7N3O2S
RSC Adv. (2016)
a=7.5691(9)Å b=8.3593(10)Å c=10.1479(12)Å
α=83.336(2)° β=88.008(2)° γ=67.0850(10)°
C33H33N5O4,C2H3N
C33H33N5O4,C2H3N
Dalton transactions (Cambridge, England : 2003) (2013) 42, 42 15113-15119
a=9.7783(6)Å b=11.5330(7)Å c=15.7730(14)Å
α=102.191(2)° β=95.289(2)° γ=112.7240(10)°
C29H31N3O3
C29H31N3O3
Dalton transactions (Cambridge, England : 2003) (2013) 42, 36 12844-12848
a=15.2374(13)Å b=14.6371(12)Å c=21.6658(18)Å
α=90.00° β=90.00° γ=90.00°
C19H12N2S
C19H12N2S
RSC Adv. (2014)
a=10.2235(9)Å b=12.4997(11)Å c=11.191(1)Å
α=90.00° β=100.6620(15)° γ=90.00°
C42H39N5O3S
C42H39N5O3S
RSC Advances (2014)
a=20.0319(9)Å b=14.3160(6)Å c=24.1507(9)Å
α=90.00° β=90.00° γ=90.00°
Hexamethylenetetramine bis(<i>o</i>-toluic acid)
C6H12N4,2(C8H8O2)
Acta Crystallographica Section C (2016) 72, 12 971-980
a=30.904(5)Å b=9.3351(16)Å c=14.353(2)Å
α=90° β=90.222(3)° γ=90°
Hexamethylenetetramine bis(<i>o</i>-toluic acid)
C6H12N4,2(C8H8O2)
Acta Crystallographica Section C (2016) 72, 12 971-980
a=30.920(3)Å b=9.3363(9)Å c=14.3462(14)Å
α=90° β=90.314(2)° γ=90°
Hexamethylenetetramine bis(<i>o</i>-toluic acid)
C6H12N4,2(C8H8O2)
Acta Crystallographica Section C (2016) 72, 12 971-980
a=30.9991(17)Å b=9.3611(5)Å c=14.3546(8)Å
α=90° β=90.0906(12)° γ=90°
Hexamethylenetetramine bis(<i>o</i>-toluic acid)
C6H12N4,2(C8H8O2)
Acta Crystallographica Section C (2016) 72, 12 971-980
a=30.975(2)Å b=9.3542(7)Å c=14.3524(10)Å
α=90° β=90.1490(14)° γ=90°
Hexamethylenetetramine bis(<i>o</i>-toluic acid)
C6H12N4,2(C8H8O2)
Acta Crystallographica Section C (2016) 72, 12 971-980
a=31.0109(19)Å b=9.3651(6)Å c=14.3551(9)Å
α=90° β=90° γ=90°
Hexamethylenetetramine bis(<i>o</i>-toluic acid)
C6H12N4,2(C8H8O2)
Acta Crystallographica Section C (2016) 72, 12 971-980
a=31.0071(16)Å b=9.3634(5)Å c=14.3544(7)Å
α=90° β=90.0656(10)° γ=90°
Hexamethylenetetramine bis(<i>o</i>-toluic acid)
C6H12N4,2(C8H8O2)
Acta Crystallographica Section C (2016) 72, 12 971-980
a=31.0133(15)Å b=9.3657(5)Å c=14.3540(7)Å
α=90° β=90° γ=90°
Hexamethylenetetramine bis(<i>o</i>-toluic acid)
C6H12N4,2(C8H8O2)
Acta Crystallographica Section C (2016) 72, 12 971-980
a=31.0259(15)Å b=9.3706(4)Å c=14.3567(7)Å
α=90° β=90° γ=90°
Hexamethylenetetramine bis(<i>o</i>-toluic acid)
C6H12N4,2(C8H8O2)
Acta Crystallographica Section C (2016) 72, 12 971-980
a=31.3604(17)Å b=9.5095(5)Å c=14.4182(8)Å
α=90° β=90° γ=90°
Isonicotinamide 4-methoxybenzoic acid
C8H8O3,C6H6N2O
Acta Crystallographica Section B (2017) 73, 2 285-295
a=20.333(2)Å b=5.1356(5)Å c=24.966(2)Å
α=90° β=90.909(6)° γ=90°
Isonicotinamide 4-methoxybenzoic acid
C8H8O3,C6H6N2O
Acta Crystallographica Section B (2017) 73, 2 285-295
a=20.296(7)Å b=5.1263(18)Å c=25.005(9)Å
α=90° β=90.95(2)° γ=90°
Isonicotinamide 4-methoxybenzoic acid
C8H8O3,C6H6N2O
Acta Crystallographica Section B (2017) 73, 2 285-295
a=20.332(2)Å b=5.1318(5)Å c=25.024(2)Å
α=90° β=90.917(6)° γ=90°
Isonicotinamide 4-methoxybenzoic acid
C8H8O3,C6H6N2O
Acta Crystallographica Section B (2017) 73, 2 285-295
a=20.088(5)Å b=5.2242(12)Å c=25.033(6)Å
α=90° β=92.308(16)° γ=90°
Isonicotinamide 4-methoxybenzoic acid
C8H8O3,C6H6N2O
Acta Crystallographica Section B (2017) 73, 2 285-295
a=20.084(2)Å b=5.2206(6)Å c=25.040(3)Å
α=90° β=92.375(8)° γ=90°
Isonicotinamide 4-methoxybenzoic acid
C8H8O3,C6H6N2O
Acta Crystallographica Section B (2017) 73, 2 285-295
a=20.126(5)Å b=5.2212(12)Å c=25.134(6)Å
α=90° β=92.401(16)° γ=90°
Isonicotinamide 4-methoxybenzoic acid
C8H8O3,C6H6N2O
Acta Crystallographica Section B (2017) 73, 2 285-295
a=20.161(4)Å b=5.2180(11)Å c=25.234(5)Å
α=90° β=92.559(14)° γ=90°
Isonicotinamide 4-methoxybenzoic acid
C8H8O3,C6H6N2O
Acta Crystallographica Section B (2017) 73, 2 285-295
a=20.246(2)Å b=5.2132(6)Å c=25.372(2)Å
α=90° β=92.557(7)° γ=90°
(2<i>E</i>)-3-(2,4-Dichlorophenyl)-1-(2,5-dichlorothiophen-3-yl)prop-2-en-1-one
C13H6Cl4OS
Acta Crystallographica Section E (2018) 74, 9 1201-1205
a=3.9867(3)Å b=13.4564(11)Å c=25.573(2)Å
α=90° β=90° γ=90°
(2<i>E</i>)-3-(3-Bromo-4-fluorophenyl)-1-(3,4-dimethoxyphenyl)prop-2-en-1-one
C17H14BrFO3
Acta Crystallographica Section E (2018) 74, 8 1063-1066
a=8.9212(12)Å b=8.6601(11)Å c=20.538(3)Å
α=90° β=96.896(3)° γ=90°
1-[2-(Adamantan-1-yl)-2-oxoethyl]pyridin-4-iminium bromide
C17H23N2O,Br
Acta Crystallographica Section E (2018) 74, 7 1030-1034
a=18.758(2)Å b=7.1508(8)Å c=11.9909(14)Å
α=90° β=98.2117(17)° γ=90°
2,2'-Methylenebis(isoindoline-1,3-dione)
C17H10N2O4
Acta Crystallographica Section E (2019) 75, 1 49-52
a=26.296(5)Å b=7.9996(15)Å c=16.987(4)Å
α=90° β=129.165(10)° γ=90°
(<i>E</i>)-3-(4-Fluorophenyl)-1-(4-nitrophenyl)prop-2-en-1-one
C15H10FNO3
Acta Crystallographica Section E (2019) 75, 1 53-57
a=3.8860(5)Å b=13.2324(16)Å c=24.199(3)Å
α=90° β=91.963(2)° γ=90°
3-Methoxybenzoic acid
C8H8O3
Acta Crystallographica Section E (2019) 75, 1 8-11
a=3.8018(4)Å b=15.6027(16)Å c=11.9755(12)Å
α=90° β=90.889(2)° γ=90°
(<i>E</i>)-4-{2-[4-(Allyloxy)phenyl]diazenyl}benzoic acid
C16H14N2O3
Acta Crystallographica Section E (2014) 70, 12 499-502
a=5.0279(4)Å b=8.9678(7)Å c=15.9913(13)Å
α=80.571(2)° β=83.874(2)° γ=88.371(2)°
3-[(4-Benzylpiperazin-1-yl)methyl]-5-(thiophen-2-yl)-2,3-dihydro-1,3,4-oxadiazole-2-thione
C18H20N4OS2
Acta Crystallographica Section E (2015) 71, 3 o175-o176
a=10.6909(5)Å b=29.3658(13)Å c=15.6179(6)Å
α=90° β=130.283(2)° γ=90°
(<i>E</i>)-3-(2-chlorophenyl)-1-(2,5-dichlorothiophen-3-yl)prop-2-en-1-one
C13H7Cl3OS
Acta Crystallographica Section E (2019) 75, 2 124-128
a=3.9017(6)Å b=22.038(3)Å c=15.127(2)Å
α=90° β=96.998(3)° γ=90°
(<i>E</i>)-1-(3-bromophenyl)-3-(2,6-dichlorophenyl)prop-2-en-1-one
C15H9BrCl2O
Acta Crystallographica, Section E (2019) 75, 2 264-267
a=3.9834(7)Å b=13.471(2)Å c=25.661(4)Å
α=90° β=92.736(4)° γ=90°
(<i>E</i>)-<i>N</i>'-(3,4-Dihydroxybenzylidene)-4-hydroxybenzohydrazide
C14H12N2O4
Acta Crystallographica Section E (2019) 75, 8 1280-1283
a=11.5352(8)Å b=7.1711(5)Å c=15.0606(10)Å
α=90° β=108.548(2)° γ=90°
4-({(1<i>E</i>,2<i>E</i>)-3-[3-(4-Fluorophenyl)-1-isopropyl-1<i>H</i>-indol-2-yl]allylidene}amino)-5-methyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C23H22FN5S
Acta Crystallographica Section E (2015) 71, 11 1411-1413
a=6.4388(8)Å b=23.482(3)Å c=14.572(3)Å
α=90° β=100.5009(19)° γ=90°
4-({(1<i>E</i>,2<i>E</i>)-3-[3-(4-Fluorophenyl)-1-isopropyl-1<i>H</i>-indol-2-yl]allylidene}amino)-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C22H20FN5S
Acta Crystallographica Section E (2015) 71, 12 1525-1527
a=9.9283(4)Å b=11.5343(5)Å c=18.4694(7)Å
α=99.8886(13)° β=94.9582(14)° γ=98.4315(14)°
2-{[(4-Iminiumyl-3-methyl-1,4-dihydropyridin-1-yl)methyl]carbamoyl}benzoate hemihydrate
C15H15N3O3,0.5(H2O)
Acta Crystallographica, Section E (2017) 73, 7 927-931
a=21.3157(18)Å b=11.9883(8)Å c=22.8642(15)Å
α=90° β=103.729(2)° γ=90°
3-{5-[3-(4-Fluorophenyl)-1-isopropyl-1<i>H</i>-indol-2-yl]-1<i>H</i>-pyrazol-1-yl}indolin-2-one ethanol monosolvate
C28H23FN4O,C2H6O
Acta Crystallographica Section E (2016) 72, 3 283-286
a=9.9754(8)Å b=10.2139(8)Å c=14.0294(11)Å
α=75.7386(15)° β=71.0062(14)° γ=83.1264(14)°
Hexamethylenetetramine bis(benzoic acid)
C6H12N4,2(C7H6O2)
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 879-890
a=6.0925(5)Å b=26.145(2)Å c=12.1017(10)Å
α=90° β=99.3633(17)° γ=90°
Hexamethylenetetramine bis(benzoic acid)
C6H12N4,2(C7H6O2)
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 879-890
a=6.1262(6)Å b=26.531(2)Å c=12.0982(11)Å
α=90° β=99.5055(16)° γ=90°
Hexamethylenetetramine bis(benzoic acid)
C6H12N4,2(C7H6O2)
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 879-890
a=6.1343(9)Å b=26.629(4)Å c=12.0933(18)Å
α=90° β=99.514(3)° γ=90°
Hexamethylenetetramine bis(benzoic acid)
C6H12N4,2(C7H6O2)
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 879-890
a=6.1398(8)Å b=26.721(4)Å c=12.0772(17)Å
α=90° β=99.554(2)° γ=90°
Hexamethylenetetramine bis(benzoic acid)
C6H12N4,2(C7H6O2)
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 879-890
a=6.1457(8)Å b=26.765(3)Å c=12.0716(16)Å
α=90° β=99.654(2)° γ=90°
Hexamethylenetetramine bis(benzoic acid)
C6H12N4,2(C7H6O2)
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 879-890
a=10.1183(18)Å b=27.015(5)Å c=7.1684(13)Å
α=90° β=90° γ=90°
Hexamethylenetetramine bis(benzoic acid)
C6H12N4,2(C7H6O2)
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 879-890
a=10.1464(11)Å b=27.166(3)Å c=7.1898(8)Å
α=90° β=90° γ=90°
Hexamethylenetetramine bis(benzoic acid)
C6H12N4,2(C7H6O2)
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 879-890
a=10.1732(13)Å b=27.291(4)Å c=7.2049(9)Å
α=90° β=90° γ=90°
Hexamethylenetetramine bis(4-methylbenzoic acid)
2(C8H8O2),C6H12N4
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 879-890
a=6.1425(4)Å b=28.0850(18)Å c=12.1822(8)Å
α=90° β=99.6957(12)° γ=90°
Hexamethylenetetramine bis(4-methylbenzoic acid)
2(C8H8O2),C6H12N4
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 879-890
a=6.202(2)Å b=28.482(10)Å c=12.225(4)Å
α=90° β=100.276(7)° γ=90°
Hexamethylenetetramine bis(4-methylbenzoic acid)
2(C8H8O2),C6H12N4
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 879-890
a=10.1948(13)Å b=7.3566(9)Å c=28.679(4)Å
α=90° β=90° γ=90°
Hexamethylenetetramine bis(4-methylbenzoic acid)
2(C8H8O2),C6H12N4
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 879-890
a=10.1958(13)Å b=7.3592(9)Å c=28.718(4)Å
α=90° β=90° γ=90°
(<i>E</i>)-3-(2-Chloro-4-fluorophenyl)-1-(2,5-dichlorothiophen-3-yl)prop-2-en-1-one
C13H6Cl3FOS
Acta crystallographica. Section E, Crystallographic communications (2018) 74, Pt 8 1134-1137
a=3.9564(8)Å b=13.367(2)Å c=25.173(5)Å
α=90° β=93.363(4)° γ=90°
(2<i>E</i>)-3-(3-Chlorophenyl)-1-(3,4-dimethoxyphenyl)prop-2-en-1-one
C17H15ClO3
Acta crystallographica. Section E, Crystallographic communications (2018) 74, Pt 7 935-938
a=9.0491(4)Å b=8.3257(4)Å c=20.2857(9)Å
α=90° β=99.4840(10)° γ=90°
(2<i>E</i>,2'<i>E</i>)-3,3'-(1,4-phenylene)bis[1-(4-hydroxyphenyl)prop-2-en-1-one] <i>N</i>,<i>N</i>-dimethylformamide disolvate
C24H18O4,2(C3H7NO)
Acta crystallographica. Section E, Crystallographic communications (2018) 74, Pt 6 835-839
a=6.0569(5)Å b=9.5801(5)Å c=11.9941(8)Å
α=72.867(2)° β=84.649(2)° γ=86.710(2)°
1-[2-([1,1'-Biphenyl]-4-yl)-2-oxoethyl]-3-methyl-1,4-dihydropyridin-4-iminium bromide
C20H19N2O,Br
Acta crystallographica. Section E, Crystallographic communications (2018) 74, Pt 5 752-756
a=15.3991(10)Å b=7.9078(5)Å c=15.7645(10)Å
α=90° β=113.0370(10)° γ=90°
(2<i>E</i>,2'<i>E</i>)-3,3'-(1,4-Phenylene)bis[1-(2,4-difluorophenyl)prop-2-en-1-one]
C24H14F4O2
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 12 1812-1816
a=12.190(6)Å b=5.972(3)Å c=38.17(2)Å
α=90° β=98.013(10)° γ=90°
2-(Benzofuran-2-yl)-2-oxoethyl 2-chlorobenzoate
C17H11ClO4
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 8 1227-1231
a=5.5333(8)Å b=11.3212(17)Å c=11.5186(18)Å
α=92.283(3)° β=91.536(3)° γ=99.638(3)°
2-(1<i>H</i>-1-Benzofuran-2-yl)-2-oxoethyl 2-nitrobenzoate
C17H11NO6
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 7 1087-1091
a=9.3022(10)Å b=28.482(3)Å c=5.5208(6)Å
α=90° β=90° γ=90°
2-(Benzofuran-2-yl)-2-oxoethyl 2-methoxybenzoate
C18H14O5
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 8 1227-1231
a=7.4094(3)Å b=9.7566(4)Å c=10.5832(5)Å
α=83.4300(10)° β=71.8080(10)° γ=87.2650(10)°
(2<i>E</i>,2'<i>E</i>)-3,3'-(1,4-Phenylene)bis[1-(2-methoxyphenyl)prop-2-en-1-one]
C26H22O4
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 6 896-900
a=7.1078(11)Å b=24.544(4)Å c=6.0449(9)Å
α=90° β=101.898(2)° γ=90°
(2<i>E</i>,2'<i>E</i>)-3,3'-(1,4-Phenylene)bis[1-(3-methoxyphenyl)prop-2-en-1-one]
C26H22O4
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 6 896-900
a=5.2626(5)Å b=15.6157(14)Å c=12.4824(11)Å
α=90° β=98.760(2)° γ=90°
(2<i>E</i>,2'<i>E</i>)-3,3'-(1,4-Phenylene)bis[1-(3,4-dimethoxyphenyl)prop-2-en-1-one]
C28H26O6
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 6 896-900
a=6.9595(6)Å b=21.0272(17)Å c=8.3297(7)Å
α=90° β=103.602(2)° γ=90°
4-aminopyridinium 4-nitrobenzoic acid 4-nitrobenzoate
C5H7N2,C7H4NO4,C7H5NO4
Acta Crystallographica Section E (2008) 64, 10 o1878-o1879
a=6.45610(10)Å b=6.85980(10)Å c=20.9055(3)Å
α=85.8260(10)° β=87.9750(10)° γ=86.1880(10)°
2-aminopyridinium p-hydroxy benzoate
C5H7N2,C7H5O3
Acta Crystallographica Section E (2008) 64, 11 o2230
a=10.0647(2)Å b=10.9369(2)Å c=10.7985(2)Å
α=90.00° β=111.0360(10)° γ=90.00°
2-Acetonyl-2-hydroxyindan-1,3-dione
C12H10O4
Acta Crystallographica Section E (2009) 65, 6 o1209
a=18.1190(2)Å b=8.81350(10)Å c=6.25850(10)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>'-[(E)-4-Bromobenzylidene]-2-(4-isobutylphenyl)propanohydrazide
C20H23BrN2O
Acta Crystallographica Section E (2009) 65, 6 o1184-o1185
a=9.14400(10)Å b=12.01100(10)Å c=33.5670(4)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 4-[3,5-bis(trifluoromethyl)phenyl]-6-methyl-2-oxo-1,2,3,4- tetrahydropyrimidine-5-carboxylate
C16H14F6N2O3
Acta Crystallographica Section E (2009) 65, 6 o1404-o1405
a=12.6876(2)Å b=7.30730(10)Å c=19.9547(3)Å
α=90.00° β=114.4430(10)° γ=90.00°
3-Aminobenzoic acid--4-nitrobenzoic acid (1/1)
C7H5NO4,C7H7NO2
Acta Crystallographica Section E (2008) 64, 12 o2333
a=25.3707(8)Å b=4.9875(2)Å c=21.7276(7)Å
α=90.00° β=109.230(2)° γ=90.00°
Bis(ferrocenecarbaldehyde 4-methylthiosemicarbazonato-κ^2^<i>N</i>^1^,<i>S</i>)zinc(II) methanol solvate
C26H28Fe2N6S2Zn,CH4O
Acta Crystallographica Section E (2009) 65, 9 m1027
a=10.94900(10)Å b=9.43650(10)Å c=28.1899(3)Å
α=90.00° β=101.4480(10)° γ=90.00°
Dimethyl 4-(4-ethoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
C19H23NO5
Acta Crystallographica Section E (2009) 65, 9 o2255-o2256
a=7.41080(10)Å b=9.7459(2)Å c=12.3359(2)Å
α=87.4120(10)° β=86.2440(10)° γ=76.4020(10)°
3-Hydroxy-3-(methoxycarbonyl)pentanedioic acid
C7H10O7
Acta Crystallographica Section E (2009) 65, 8 o1843
a=12.7110(4)Å b=5.8323(2)Å c=23.8844(7)Å
α=90.00° β=90.00° γ=90.00°
(<i>Z</i>)-1-(2,5-Dichloro-3-thienyl)ethanone semicarbazone
C7H7Cl2N3OS
Acta Crystallographica Section E (2009) 65, 8 o1852-o1853
a=13.0796(2)Å b=10.4316(2)Å c=14.4352(2)Å
α=90° β=94.5990(10)° γ=90°
(<i>Z</i>)-3-(2-{2-[1-(4-Hydroxyphenyl)ethylidene]hydrazin-1-yl}-1,3- thiazol-4-yl)-2<i>H</i>-chromen-2-one
C20H15N3O3S
Acta Crystallographica Section E (2010) 66, 7 o1632-o1633
a=9.1117(16)Å b=16.225(3)Å c=12.113(2)Å
α=90.00° β=104.657(3)° γ=90.00°
Cholest-5-en-7-one
C27H44O
Acta Crystallographica Section E (2010) 66, 7 o1668
a=6.3468(13)Å b=11.517(3)Å c=15.678(3)Å
α=90.00° β=91.470(5)° γ=90.00°
8-Hydroxyquinolinium 2-carboxyacetate
C9H8NO,C3H3O4
Acta Crystallographica Section E (2010) 66, 9 o2254
a=8.7089(4)Å b=5.2930(2)Å c=23.4672(9)Å
α=90.00° β=90.999(3)° γ=90.00°
2-Amino-5-methylpyridinium 2-hydroxybenzoate
C6H9N2,C7H5O3
Acta Crystallographica Section E (2010) 66, 9 o2255-o2256
a=13.211(7)Å b=7.170(4)Å c=14.324(7)Å
α=90.00° β=104.668(11)° γ=90.00°
Bis(2-amino-5-bromopyridinium) fumarate dihydrate
2(C5H6BrN2),C4H2O42,2H2O
Acta Crystallographica Section E (2010) 66, 9 o2252-o2253
a=8.37170(10)Å b=16.5354(2)Å c=6.78460(10)Å
α=90.00° β=108.3360(10)° γ=90.00°
Ethyl 1-<i>tert</i>-butyl-5-phenyl-1<i>H</i>-pyrazole-4-carboxylate
C16H20N2O2
Acta Crystallographica Section E (2010) 66, 9 o2228
a=9.0665(2)Å b=9.3351(2)Å c=10.5408(3)Å
α=110.4500(10)° β=113.9870(10)° γ=97.645(2)°
3-Ethyl-6-[3-(4-fluorophenyl)-1<i>H</i>-pyrazol-4-yl]-1,2,4- triazolo[3,4-<i>b</i>][1,3,4]thiadiazole
C14H11FN6S
Acta Crystallographica Section E (2010) 66, 11 o2799-o2800
a=35.053(2)Å b=3.8463(2)Å c=9.9482(6)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 1,5-diphenyl-1<i>H</i>-pyrazole-4-carboxylate
C18H16N2O2
Acta Crystallographica Section E (2010) 66, 9 o2282-o2283
a=9.2015(8)Å b=10.4638(9)Å c=16.9332(15)Å
α=97.515(2)° β=104.605(2)° γ=104.578(2)°
3-butyl-1-({3-[(3-butylimidazol-1-ium-1-yl)methyl]-5- methylphenyl}methyl)imidazol-1-ium bis(hexafluoridophosphate) 3,5-Bis(3-butylimidazolium-1-ylmethyl)toluene bis(hexafluorophosphate)
C23H34N42,2(F6P)
Acta Crystallographica Section E (2010) 66, 11 o2797-o2798
a=9.62070(10)Å b=11.18010(10)Å c=27.9277(3)Å
α=90.00° β=102.4160(10)° γ=90.00°
(<i>E</i>)-<i>N</i>'-[(<i>E</i>)-3-(4-Hydroxy-3- methoxyphenyl)allylidene]isonicotinohydrazide
C16H15N3O3
Acta Crystallographica Section E (2010) 66, 2 o291
a=5.04700(10)Å b=28.9314(6)Å c=9.6446(2)Å
α=90.00° β=90.0100(10)° γ=90.00°
2,3-Dibromo-3-(5-nitro-2-furyl)-1-(4-nitrophenyl)propan-1-one
C13H8Br2N2O6
Acta Crystallographica Section E (2010) 66, 12 o3128
a=12.1902(2)Å b=12.2006(2)Å c=9.9761(2)Å
α=90.00° β=96.2820(10)° γ=90.00°
4-(1,2,4-Triazol-1-yl)aniline
C8H8N4
Acta Crystallographica Section E (2011) 67, 1 o164
a=5.54880(10)Å b=7.3656(2)Å c=19.5477(5)Å
α=90.00° β=99.416(2)° γ=90.00°
2-(4-Methylphenoxy)acetohydrazide
C9H12N2O2
Acta Crystallographica Section E (2011) 67, 1 o165
a=6.3833(2)Å b=4.07550(10)Å c=35.9741(12)Å
α=90.00° β=90.018(2)° γ=90.00°
Potassium bis[bis(1-benzyl-3-methylimidazolium)silver(I)] tris(hexafluoridophosphate)
K,2(C22H24AgN4),3(PF6)
Acta Crystallographica Section E (2011) 67, 1 m97-m98
a=19.917(2)Å b=23.047(2)Å c=11.5787(12)Å
α=90.00° β=103.108(3)° γ=90.00°
2-Phenoxyacetohydrazide
C8H10N2O2
Acta Crystallographica Section E (2010) 66, 1 o53-o54
a=6.3397(8)Å b=4.0590(6)Å c=15.948(2)Å
α=90.00° β=99.218(10)° γ=90.00°
2-(2-Chlorophenoxy)acetohydrazide
C8H9ClN2O2
Acta Crystallographica Section E (2010) 66, 1 o31-o32
a=15.2384(5)Å b=3.92690(10)Å c=16.8843(6)Å
α=90.00° β=117.269(2)° γ=90.00°
4-Amino-3-(1-naphthyloxymethyl)-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C13H12N4OS
Acta Crystallographica Section E (2010) 66, 1 o29-o30
a=7.00230(10)Å b=24.0785(4)Å c=8.09150(10)Å
α=90.00° β=113.4040(10)° γ=90.00°